Cardiometabolic Risk in Pregnancy and Postpartum

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorForgive Avorgbedor

About this trial

The goal of this study is to evaluate changes in blood pressure and early cardiovascular risk markers and to determine whether a postpartum education intervention can improve cardiovascular risk monitoring among pregnant women in their third trimester through six months postpartum in Accra, Ghana. The study includes women aged 18 years and older with and without pregnancy-related cardiometabolic complications. Findings from this study will inform the development of scalable postpartum screening and intervention strategies to reduce long-term cardiovascular disease risk among women.

Eligibility criteria

Qualifiers

Singleton pregnancy

18 years and older

3rd trimester of pregnancy at enrollment

Will be living in the area for the study duration

Disqualifiers

Multiple births

Diagnosed CVD or diabetes prior to pregnancy

Renal or other serious maternal diseases pre-pregnancy

Trial design

Treatments tested in this trial

  • Postpartum Cardiovascular Disease (CVD) Risk Reduction Program
  • Enhanced Postpartum Care

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Forgive Avorgbedor

Lead sponsor

University of North Carolina, Greensboro

Sponsor institution